Renowned psychiatrist Dr. Anish Shah, MD of Siyan Clinical, the North Bay's largest outpatient psychiatric treatment center, offers a successful and cost-effective modality for treatment of clinical depression, particularly in individuals.
Biogen has signed an exclusive option agreement to buy Japan-based biotechnology company TMS’ TMS-007 drug candidate being developed for the treatment of acute ischemic stroke (AIS).